PNU-96391
CAS No. 146798-66-5
PNU-96391( OSU-6162 | PNU96391 | OSU6162 | PNU 96391 | OSU 6162 )
Catalog No. M27915 CAS No. 146798-66-5
PNU-96391 is an antagonist of dopamine D2 and a partial agonist of 5-HT2A. PNU-96391 can be used in research on the treatment of chronic diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 393 | Get Quote |
|
10MG | 581 | Get Quote |
|
25MG | 888 | Get Quote |
|
50MG | 1242 | Get Quote |
|
100MG | 1674 | Get Quote |
|
500MG | 3348 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePNU-96391
-
NoteResearch use only, not for human use.
-
Brief DescriptionPNU-96391 is an antagonist of dopamine D2 and a partial agonist of 5-HT2A. PNU-96391 can be used in research on the treatment of chronic diseases.
-
DescriptionPNU-96391 is an antagonist of dopamine D2 and a partial agonist of 5-HT2A. PNU-96391 can be used in research on the treatment of chronic diseases.
-
In Vitro——
-
In Vivo——
-
SynonymsOSU-6162 | PNU96391 | OSU6162 | PNU 96391 | OSU 6162
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorPAI-1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number146798-66-5
-
Formula Weight281.41
-
Molecular FormulaC15H23NO2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCN1CC(C2=CC=CC(S(=O)(C)=O)=C2)CCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jacobsen JS, et al. Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade. Proc Natl Acad Sci U S A. 2008 Jun 24;105(25):8754-9.
molnova catalog
related products
-
Ro 10-5824 dihydroch...
Ro 10-5824 dihydrochloride is a selective agonist of dopamine D4 receptor partial, (Ki of 5.2 nM).
-
Dexpramipexole
A partial/full agonist of dopamine receptor with Ki of 3.9/2.2/0.5/5.1 nM for D2S/D2L/D3/D4, respeectively.
-
GSK598809 hydrochlor...
GSK598809 hydrochloride is a potent, selective, CNS penetrant and orally bioavailable dopamine D3 receptor antagonist with pKi of 8.9; displays >100-fold selectivity over D2 and H1 receptors.